Hoerter Steven L.
Transactions
50
Companies
9
Filings
17
CIK
0001533451
Recent Transactions
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Purchase
- Award
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
- Disposition from Tender
- Disposition to Issuer
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- Sale
- Award
- Sale
- Award
- Award
- Sale
- Award
- Sale
- Award
- Tax Payment
- Award
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- Tax Payment
- Tax Payment
- Award
- Exercise/Conversion
Companies
9- $AGIO
AGIOS PHARMACEUTICALS, INC.
Chief Commercial Officer
- $CCCC
C4 Therapeutics, Inc.
Director
Clovis Oncology, Inc.
See Remarks
CONSTELLATION PHARMACEUTICALS INC
Director
Deciphera Pharmaceuticals, Inc.
Director, President and CEO
Ignyta, Inc.
Director
- $MBX
MBX Biosciences, Inc.
Director, President and CEO
- $ORIC
Oric Pharmaceuticals, Inc.
Director
- $YARW
Yarrow Bioscience, Inc.
Director
Recent Filings
17- 4
Hoerter Steven L.
Aug 4, 2026
- 4
Hoerter Steven L.
Jun 26, 2026
- 4
Hoerter Steven L.
Jun 5, 2026
- 4
Hoerter Steven L.
May 4, 2026
- 4/A
Hoerter Steven L.
Apr 22, 2026
- 4/A
Hoerter Steven L.
Apr 22, 2026
- 4
Hoerter Steven L.
Jan 6, 2026
- 4
Hoerter Steven L.
Nov 25, 2025
- 4
Hoerter Steven L.
Nov 7, 2025
- 4
Hoerter Steven L.
Oct 20, 2025
- 4
Hoerter Steven L.
Jun 20, 2025
- 4
Hoerter Steven L.
Jun 6, 2025
- 4
Hoerter Steven L.
Apr 9, 2025
- 4
Hoerter Steven L.
Jan 6, 2025
- 4
Hoerter Steven L.
Nov 21, 2024
- 4
Hoerter Steven L.
Jun 14, 2024
- 4
Hoerter Steven L.
Jun 11, 2024
Address
C/O MBX BIOSCIENCES INC. 11711 N. MERIDIAN STREET, SUITE 300
CARMEL, IN, 46032